117 related articles for article (PubMed ID: 12383321)
1. Ultrasonographic features of the endometrium and the ovaries in women on etonogestrel implant.
Van den Bosch T; Donders GG; Riphagen I; Debois P; Ameye L; De Brabanter J; Van Huffel S; Van Schoubroeck D; Timmerman D
Ultrasound Obstet Gynecol; 2002 Oct; 20(4):377-80. PubMed ID: 12383321
[TBL] [Abstract][Full Text] [Related]
2. The pharmacodynamics and efficacy of Implanon. An overview of the data.
Croxatto HB; Mäkäräinen L
Contraception; 1998 Dec; 58(6 Suppl):91S-97S. PubMed ID: 10095979
[TBL] [Abstract][Full Text] [Related]
3. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.
Mäkäräinen L; van Beek A; Tuomivaara L; Asplund B; Coelingh Bennink H
Fertil Steril; 1998 Apr; 69(4):714-21. PubMed ID: 9548163
[TBL] [Abstract][Full Text] [Related]
4. Endometrial effects of etonogestrel (Implanon) contraceptive implant.
Varma R; Mascarenhas L
Curr Opin Obstet Gynecol; 2001 Jun; 13(3):335-41. PubMed ID: 11396660
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant.
Bennink HJ
Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():12-20. PubMed ID: 11246602
[TBL] [Abstract][Full Text] [Related]
6. Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel.
Davies GC; Feng LX; Newton JR; Van Beek A; Coelingh-Bennink HJ
Contraception; 1993 Mar; 47(3):251-61. PubMed ID: 8462316
[TBL] [Abstract][Full Text] [Related]
7. Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant.
Croxatto HB
Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():21-8. PubMed ID: 11246604
[TBL] [Abstract][Full Text] [Related]
8. The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users.
Lazorwitz A; Davis A; Swartz M; Guiahi M
Contraception; 2017 Jun; 95(6):571-577. PubMed ID: 28288788
[TBL] [Abstract][Full Text] [Related]
9. A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China.
Zheng SR; Zheng HM; Qian SZ; Sang GW; Kaper RF
Eur J Contracept Reprod Health Care; 1999 Jun; 4(2):85-93. PubMed ID: 10427483
[TBL] [Abstract][Full Text] [Related]
10. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
[TBL] [Abstract][Full Text] [Related]
11. Etonogestrel implant (Implanon) for contraception.
Drug Ther Bull; 2001 Aug; 39(8):57-9. PubMed ID: 11526801
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
13. Sonographic imaging in progestin users and future directions.
Varma R; Mascarenhas L
Ultrasound Obstet Gynecol; 2002 Oct; 20(4):322-6. PubMed ID: 12383311
[No Abstract] [Full Text] [Related]
14. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
[TBL] [Abstract][Full Text] [Related]
15. Norplant users with irregular bleeding. Ultrasonographic assessment and evaluation of serum concentrations of estradiol and progesterone.
Kaewrudee S; Taneepanichskul S
J Reprod Med; 2000 Dec; 45(12):983-6. PubMed ID: 11153258
[TBL] [Abstract][Full Text] [Related]
16. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
Langer RD; Landgren BM; Rymer J; Helmond FA;
Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
[TBL] [Abstract][Full Text] [Related]
17. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon.
Affandi B
Contraception; 1998 Dec; 58(6 Suppl):99S-107S. PubMed ID: 10095980
[TBL] [Abstract][Full Text] [Related]
18. Vaginal bleeding disturbances and implantable contraceptives.
Hickey M; d'Arcangues C
Contraception; 2002 Jan; 65(1):75-84. PubMed ID: 11861057
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.
Lazorwitz A; Aquilante CL; Dindinger E; Harrison M; Sheeder J; Teal S
Obstet Gynecol; 2019 Oct; 134(4):807-813. PubMed ID: 31503152
[TBL] [Abstract][Full Text] [Related]
20. Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants.
Faúndes A; Alvarez F; Brache V; Cochón L
Hum Reprod; 1998 Jan; 13(1):188-91. PubMed ID: 9512255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
